<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03939299</url>
  </required_header>
  <id_info>
    <org_study_id>CLARIFY-CTO</org_study_id>
    <nct_id>NCT03939299</nct_id>
  </id_info>
  <brief_title>OCT Explores Vascular Response and Healing Profile After Stenting in CTO</brief_title>
  <official_title>Optical Coherence Tomography Imaging Explores Long-term vasculAR Response and Healing profIle After successFul coronarY Stenting in Chronic Total Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      True-false-true occurred during wire penetration in coronary CTO procedure. Subintimal&#xD;
      stenting influences vascular response. Intravenous ultrasound confirmed wire position in the&#xD;
      procedure. Then stenting procedure was performed. Optical coherence tomography was used for&#xD;
      exploring long-term vascular response and healing profile after successful coronary stenting&#xD;
      in CTO lesions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic total occlusions (CTOs) are defined as coronary lesions with thrombolysis in&#xD;
      myocardial infarction (TIMI) grade flow of 0 and present for more than 3 months. CTO is&#xD;
      commonly recognized as the toughest lesion subset to be treated by percutaneous coronary&#xD;
      interventions. With the remarkable progress in the technologies and techniques achieved in&#xD;
      the PCI for CTO over the last decade, the rate of procedural success increased to 80-90%.&#xD;
      Chronic total occlusion is associated with a higher incidence of malapposition and uncovered&#xD;
      stent struts. At present, four strategies were used for CTO lesions, including: ante-grade&#xD;
      wire escalation, ante-grade dissection reentry (ADR), retro-grade wire escalation, and&#xD;
      retrograde dissection reentry (RDR). True-false-true occurred during wire penetration.&#xD;
      Subintimal stenting influences vascular response. Intravenous ultrasound (IVUS) confirmed&#xD;
      wire position in the procedure. Then stenting procedure was performed according to standard&#xD;
      routine. Optical coherence tomography (OCT) was used for exploring long-term vascular&#xD;
      response and healing profile after successful coronary stenting in CTO lesions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All enrolled patients received optical coherence tomography examination after successful stening at the chronic total occlusion lesion.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>long-term minimal stent area</measure>
    <time_frame>9-12 month after index procedure</time_frame>
    <description>measured through OCT imaging result</description>
  </primary_outcome>
  <primary_outcome>
    <measure>long-term stent thrombosis</measure>
    <time_frame>9-12 month after index procedure</time_frame>
    <description>measured through OCT imaging result</description>
  </primary_outcome>
  <primary_outcome>
    <measure>long-term stent neointima</measure>
    <time_frame>9-12 month after index procedure</time_frame>
    <description>measured through OCT imaging result</description>
  </primary_outcome>
  <primary_outcome>
    <measure>long-term stent malapposition</measure>
    <time_frame>9-12 month after index procedure</time_frame>
    <description>measured through OCT imaging result</description>
  </primary_outcome>
  <primary_outcome>
    <measure>immediately minimal stent area</measure>
    <time_frame>in the procedure</time_frame>
    <description>measured through OCT imaging result</description>
  </primary_outcome>
  <primary_outcome>
    <measure>immediately stent malapposition</measure>
    <time_frame>in the procedure</time_frame>
    <description>measured through OCT imaging result</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiovascular Events</measure>
    <time_frame>9-12 month after index procedure</time_frame>
    <description>clinical follow-up record</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Chronic Total Occlusion of Coronary Artery</condition>
  <arm_group>
    <arm_group_label>OCT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients, whose coronary chronic total occlusion lesion was successfully implanted stent, received optical coherence tomography imaging immediately and at 9-12 months after index procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>OCT</intervention_name>
    <description>Patients with coronary chronic total occlusion received successful stenting. Optimal coherence tomography imaged immediately and at 9-12 months after the index procedure to explore long-term vascular response and healing profile.</description>
    <arm_group_label>OCT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18~85 years old;&#xD;
&#xD;
          -  Agree percutaneous coronary intervention without related contraindications;&#xD;
&#xD;
          -  Chronic total occlusion confirmed by clinical and angiographic data, predicted high&#xD;
             successful rate of stent implantation;&#xD;
&#xD;
          -  Subjects (or legal guardians) understanding the testing requirements and procedures,&#xD;
             and providing written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects associated with drugs allergy (such as contrast, sirolimus, or&#xD;
             structure-related compounds fluorinated polymers, thienopyridine or aspirin);&#xD;
&#xD;
          -  Subjects with active peptic ulcer, active gastrointestinal (GI) bleeding or other&#xD;
             bleeding diathesis or coagulopathy;&#xD;
&#xD;
          -  Subjects being suffered from other serious illness (such as cancer, congestive heart&#xD;
             failure), which may cause drop in life expectancy to less than 12 months;&#xD;
&#xD;
          -  Pregnant or breastfeeding women;&#xD;
&#xD;
          -  Refused this trial;&#xD;
&#xD;
          -  Subjects with severe liver or renal dysfunction (ALT &gt;5×ULN，eGFR&lt; 30ml/min/1.73mm2 or&#xD;
             Scr&gt;200 mmol/L);&#xD;
&#xD;
          -  Active bleeding;&#xD;
&#xD;
          -  Bleeding diathesis or coagulopathy, malignant tumors;&#xD;
&#xD;
          -  Contraindication of anticoagulant drugs;&#xD;
&#xD;
          -  Subjects with other situation not suitable for the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juying Qian, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hongbo Yang, M.D.</last_name>
    <phone>008613585890793</phone>
    <email>yang.hongbo@zs-hospital.sh.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhangwei Chen, Ph.D.</last_name>
    <phone>008613918612111</phone>
    <email>chen.zhangwei@zs-hospital.sh.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongshan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongbo Yang, M.D.</last_name>
      <phone>008613585890793</phone>
      <email>yang.hongbo@zs-hospital.sh.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>April 29, 2019</study_first_submitted>
  <study_first_submitted_qc>May 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2019</study_first_posted>
  <last_update_submitted>May 3, 2019</last_update_submitted>
  <last_update_submitted_qc>May 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>subintimal stenting</keyword>
  <keyword>vascular response and healing</keyword>
  <keyword>optical coherence tomography</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

